HITK Share Price

Open 43.50 Change Price %
High 43.50 1 Day -0.01 -0.02
Low 43.48 1 Week 0.00 0.00
Close 43.49 1 Month 0.00 0.00
Volume 149971 1 Year 0.00 0.00
52 Week High 12.00
52 Week Low 0.00
HITK Important Levels
Resistance 2 43.51
Resistance 1 43.50
Pivot 43.49
Support 1 43.48
Support 2 43.47
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
DSTI 0.00 -100.00%
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK)

HITK Technical Analysis 5
As on 16th Apr 2014 HITK Share Price closed @ 43.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 40.23 & Strong Buy for SHORT-TERM with Stoploss of 43.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
HITK Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
HITK Other Details
Segment EQ
Market Capital 430674656.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
HITK Address
HITK
N/A
HITK Latest News
Interactive Technical Analysis Chart Hi-Tech Pharmacal Co., Inc. ( HITK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Hi-Tech Pharmacal Co., Inc.
HITK Business Profile
Hi-Tech Pharmacal Co., Inc. (Hi-Tech), is a specialty manufacturer and marketer of prescription, over-the-counter (OTC) and nutritional products. Hi-Tech develops, manufactures and markets products in three categories: generics, prescription brands and OTC brands. The Company produces a range of products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care and other conditions. Its generic products are primarily prescription items and include oral solutions and suspensions, topical creams and ointments, as well as nasal sprays. In January 2012, the Company acquired marketing and distribution rights to a topical wound gel product from Glycobiosciences, Inc. In March 2012, the Company acquired several homeopathic branded nasal spray products, including Sinus Buster and Allergy Buster from Dynova Laboratories, Inc.